FIS vs LAB · P/E 7.9, rev $2.60B vs rev $174.4M
Fidelity National Information Services Inc (FIS) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported FIS revenue for 2024-12-31 was $2.60B. Net income was $282.0M. Revenue was up 1.1% from 2024-09-30 to 2024-12-31. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
FIS currently screens at market cap $21.12B and trailing P/E 7.9. LAB currently screens at market cap $317.1M.
Not investment advice. Open the FIS and LAB stock pages for the full models.
Not investment advice.